These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 6619039)

  • 41. Pharmacokinetics of mezlocillin in patients with hepatobiliary dysfunction.
    Meyers BR; Srulevitch ES; Sacks HS; Hirschman SZ; Worner TM; Wormser GP; Jacobson J
    J Antimicrob Chemother; 1986 Dec; 18(6):709-13. PubMed ID: 3818496
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Circulation of isoxazolyl penicillins in surgical patients].
    Iakovlev VP; Kopeĭko IP; Govorovich EA; Marshak AM; Nikishina OP
    Antibiotiki; 1971 Oct; 16(10):944-8. PubMed ID: 5138889
    [No Abstract]   [Full Text] [Related]  

  • 43. [Study of the pharmacokinetics of dicloxacillin used parenterally in an experiment].
    Vasil'ev VK
    Antibiotiki; 1977 May; 22(5):450-4. PubMed ID: 879730
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Clinical studies with a mezlocillin-oxacillin combination in a children's intensive care ward].
    Schöch G
    Arzneimittelforschung; 1979; 29(12a):2017-20. PubMed ID: 543916
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Investigation of mezlocillin disposition with a porcine model.
    DiPiro JT; Davis JB; Boudinot FD; Cheung RP; Sisley JF
    Biopharm Drug Dispos; 1989; 10(6):563-72. PubMed ID: 2611357
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Biliary excretion of mezlocillin in patients with hepatic disease.
    Hildebrandt R; Gundert-Remy U; Raedsch R; Sieg A; Stiehl A
    Int J Clin Pharmacol Ther; 1995 Jul; 33(7):384-7. PubMed ID: 7582392
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Effect of dose on pharmacokinetics and serum bactericidal activity of mezlocillin.
    Flaherty JF; Barriere SL; Mordenti J; Gambertoglio JG
    Antimicrob Agents Chemother; 1987 Jun; 31(6):895-8. PubMed ID: 3619421
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Use of hydroxyapatite for determination of antibiotic concentrations in bone].
    Wittmann DH; Berghoff D; Reynders-Frederix V; Schassan HH
    Arzneimittelforschung; 1983; 33(3):423-6. PubMed ID: 6307318
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Mezlocillin pharmacokinetics in pediatric oncology patients.
    Kramer WG; Pickering LK; Culbert S; Frankel LS
    Antimicrob Agents Chemother; 1984 Jan; 25(1):62-4. PubMed ID: 6703685
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The pharmacokinetics of temocillin in patients with normal and impaired renal function.
    Boelaert J; Daneels R; Schurgers M; Lambert AM; Van Landuyt HW; Mellows G; Wolf J; Swaisland AJ
    J Antimicrob Chemother; 1983 Apr; 11(4):349-56. PubMed ID: 6853404
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Developmental pharmacokinetics of mezlocillin in 4 newborn infants.
    Jungbluth GL; Wirth FH; Rubio TT; Janicke DM; Jusko WJ
    Dev Pharmacol Ther; 1988; 11(6):317-21. PubMed ID: 3229277
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Pharmacokinetics and dosage adjustment of cefotiam in renal impaired patients.
    Rouan MC; Binswanger U; Bammatter F; Theobald W; Schoeller JP; Guibert J
    J Antimicrob Chemother; 1984 Jun; 13(6):611-8. PubMed ID: 6088464
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Dose-dependent pharmacokinetics of azlocillin compared to mezlocillin.
    Bergan T; Thorsteinsson SB; Steingrimsson O
    Chemotherapy; 1982; 28(3):160-70. PubMed ID: 6212204
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Penetration of ampicillin and dicloxacillin into tissue cage fluid in rabbits: relation to serum and tissue protein binding.
    Cars O; Henning C; Holm SE
    Scand J Infect Dis; 1981; 13(1):69-74. PubMed ID: 7244562
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Clinical pharmacokinetics of gabapentin after administration of gabapentin enacarbil extended-release tablets in patients with varying degrees of renal function using data from an open-label, single-dose pharmacokinetic study.
    Lal R; Sukbuntherng J; Luo W; Chen D; Blumenthal R; Ho J; Cundy KC
    Clin Ther; 2012 Jan; 34(1):201-13. PubMed ID: 22206794
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Which pharmacokinetic parameters are of interest in the choice of antibiotics?].
    Hagberg R
    Lakartidningen; 1978 Jun; 75(24):2386-8. PubMed ID: 672309
    [No Abstract]   [Full Text] [Related]  

  • 57. [The effect of infusion rate on pharmacokinetic parameters of azlocillin and mezlocillin].
    Haen E; Remien J; Richter E; Frank U; Adam D
    Arzneimittelforschung; 1985; 35(5):864-8. PubMed ID: 4026911
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Kinetics of ampicillin, oxacillin and carbenicillin after a short intravenous infusion in man].
    Wirth K; Hengstmann JH; Langebartels FH; Träger S
    Arzneimittelforschung; 1976; 26(9):1709-15. PubMed ID: 1036706
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Kinetics of beta-lactamase inactivation of penicillins. II. Effect of competitive inhibitors.
    Hou JP; Poole JW
    Chemotherapy; 1973; 19(3):129-47. PubMed ID: 4203115
    [No Abstract]   [Full Text] [Related]  

  • 60. Pharmacokinetics of dicloxacillin in serum and aortic wall during aneurysmal surgery.
    Almgren B; Cars O; Eriksson I; Erlendsdóttir H
    Acta Chir Scand; 1986 Jan; 152():19-21. PubMed ID: 3953214
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.